US pharma tariffs would raise US drug costs by $51 billion annually, report finds
AbbVie hikes its outlook on the back of two powerhouse drugs
Big Pharma is investing billions in AI— and the value is finally starting to show
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
*please scroll down for all the latest news *